國立虎尾科技大學 |

Neuroproteomics as a Tool for Understanding Schizophrenia

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Neuroproteomics as a Tool for Understanding Schizophrenia/ edited by Daniel Martins-de-Souza.
other author:	Martins-de-Souza, Daniel.
Description:	VIII, 143 p. 12 illus., 11 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Genomics. -
Online resource:	https://doi.org/10.1007/978-3-030-97182-3
ISBN:	9783030971823

Neuroproteomics as a Tool for Understanding Schizophrenia
Neuroproteomics as a Tool for Understanding Schizophrenia[electronic resource] /edited by Daniel Martins-de-Souza. - 1st ed. 2022. - VIII, 143 p. 12 illus., 11 illus. in color.online resource. - Proteomics, Metabolomics, Interactomics and Systems Biology,14002730-6224 ;. - Proteomics, Metabolomics, Interactomics and Systems Biology,1055.

1. Postmortem brains: what can proteomics tell us about the sources of schizophrenia? -- 2. What can we learn from animal models to study schizophrenia? -- 3. Modeling schizophrenia in vitro: challenges and insights on studying brain cell -- 4. Schizophrenia outside the brain -- 5. Molecular features triggered by antipsychotic medication in brain cells -- 6. Known and Unexplored Post-Translational Modification Pathways in Schizophrenia -- 7. Molecular findings guiding the modulation of the endocannabinoid system as a potential target to treat schizophrenia -- 8. Metabolomics: A powerful tool to understand the schizophrenia biology -- 9. Modulating specific pathways in vitro to understand the synaptic dysfunction of schizophrenia -- 10. Proteomics and schizophrenia: the evolution of a great partnership.

Over the past decade, neuroproteomics has shed light on the molecular features of schizophrenia by depicting biological processes involved with its establishment, maintenance and treatment. These studies have also pointed to potential biomarkers applicable to diagnosis and medication monitoring. Edited by a leader in the field of neuroproteomics with contributions from subject experts, this new volume will address recent findings and compile evidence from difference perspectives—such as human samples, animal models, pluripotent stem cell-derived in vitro pre-clinical models—and provide findings to inform the development of innovative future treatment strategies. This volume will be useful for a broad audience of researchers and professionals, including biologists, neurologists, psychiatrists, analytical chemists, and pharmacists, among others. Provides comprehensive overview on how neuroproteomics helped depicting the molecular features of schizophrenia Addresses biological processes, treatment strategies, and recent research findings associated to schizophrenia Addresses current research challenges, future strategies, and clinical applications.

ISBN: 9783030971823

Standard No.: 10.1007/978-3-030-97182-3doiSubjects--Topical Terms:

578973
Genomics.

LC Class. No.: QH447-447.8

Dewey Class. No.: 572.86

Neuroproteomics as a Tool for Understanding Schizophrenia
LDR:03418nam a22003975i 4500 001 1089414
003 DE-He213
005 20220805131058.0
007 cr nn 008mamaa
008 221228s2022 sz | s |||| 0|eng d
020 $a 9783030971823 $9 978-3-030-97182-3
024 7 $a 10.1007/978-3-030-97182-3 $2 doi
035 $a 978-3-030-97182-3
050 4 $a QH447-447.8
072 7 $a PSAK $2 bicssc
072 7 $a SCI029000 $2 bisacsh
072 7 $a PSAK $2 thema
082 0 4 $a 572.86 $2 23
245 1 0 $a Neuroproteomics as a Tool for Understanding Schizophrenia $h [electronic resource] / $c edited by Daniel Martins-de-Souza.
250 $a 1st ed. 2022.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a VIII, 143 p. 12 illus., 11 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Proteomics, Metabolomics, Interactomics and Systems Biology, $x 2730-6224 ; $v 1400
505 0 $a 1. Postmortem brains: what can proteomics tell us about the sources of schizophrenia? -- 2. What can we learn from animal models to study schizophrenia? -- 3. Modeling schizophrenia in vitro: challenges and insights on studying brain cell -- 4. Schizophrenia outside the brain -- 5. Molecular features triggered by antipsychotic medication in brain cells -- 6. Known and Unexplored Post-Translational Modification Pathways in Schizophrenia -- 7. Molecular findings guiding the modulation of the endocannabinoid system as a potential target to treat schizophrenia -- 8. Metabolomics: A powerful tool to understand the schizophrenia biology -- 9. Modulating specific pathways in vitro to understand the synaptic dysfunction of schizophrenia -- 10. Proteomics and schizophrenia: the evolution of a great partnership.
520 $a Over the past decade, neuroproteomics has shed light on the molecular features of schizophrenia by depicting biological processes involved with its establishment, maintenance and treatment. These studies have also pointed to potential biomarkers applicable to diagnosis and medication monitoring. Edited by a leader in the field of neuroproteomics with contributions from subject experts, this new volume will address recent findings and compile evidence from difference perspectives—such as human samples, animal models, pluripotent stem cell-derived in vitro pre-clinical models—and provide findings to inform the development of innovative future treatment strategies. This volume will be useful for a broad audience of researchers and professionals, including biologists, neurologists, psychiatrists, analytical chemists, and pharmacists, among others. Provides comprehensive overview on how neuroproteomics helped depicting the molecular features of schizophrenia Addresses biological processes, treatment strategies, and recent research findings associated to schizophrenia Addresses current research challenges, future strategies, and clinical applications.
650 0 $a Genomics. $3 578973
650 0 $a Bioinformatics. $3 583857
650 0 $a Neurosciences. $3 593561
650 2 4 $a Computational and Systems Biology. $3 1365723
650 2 4 $a Neuroscience. $3 569964
700 1 $a Martins-de-Souza, Daniel. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1056843
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030971816
776 0 8 $i Printed edition: $z 9783030971830
830 0 $a Proteomics, Metabolomics, Interactomics and Systems Biology, $x 2730-6216 ; $v 1055 $3 1285713
856 4 0 $u https://doi.org/10.1007/978-3-030-97182-3
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)